[Congressional Record Volume 172, Number 71 (Wednesday, April 22, 2026)]
[Senate]
[Pages S1998-S1999]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5159. Mr. SANDERS submitted an amendment intended to be proposed 
by him to the concurrent resolution S. Con. Res. 33, setting forth the 
congressional budget for the United States Government for fiscal year 
2026 and setting forth the appropriate budgetary levels for fiscal 
years 2027 through 2035; which was ordered to be on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO REDUCING 
                   THE PRICE OF PRESCRIPTION DRUGS, WHICH SHALL 
                   INCLUDE MOST FAVORED NATION DRUG PRICING.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this

[[Page S1999]]

     resolution, and make adjustments to the pay-as-you-go ledger, 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to reducing the price of prescription drugs in the 
     United States by more than 50 percent, which shall include 
     Most Favored Nation drug pricing so that Americans pay no 
     more for prescription drugs than the Europeans or Canadians, 
     by the amounts provided in such legislation for those 
     purposes, provided that such legislation would not increase 
     the deficit over the period of the total of fiscal years 2026 
     through 2035.
                                 ______